The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine in cancer treatment. The challenge is designing drugs that do this ...

The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...

The field of pharmacogenomics integrates genomic data with pharmacology to customize drug treatments for individual patients. This presentation aims to educate clinical researchers and healthcare ...

The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

Kitov Pharmaceuticals (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...